CG Oncology, Inc. Common stock
CGON Real Time Price USDRecent trades of CGON by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CGON's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
CGON Revenue by Segment or Geography
New patents grants
-
Patent Title: Methods of treating solid or lymphatic tumors by combination therapy Sep. 17, 2024
-
Patent Title: Methods of treating bladder cancer Mar. 07, 2023
-
Patent Title: Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus cg0070 and an immune checkpoint inhibitor Nov. 15, 2022
-
Patent Title: Methods of treating bladder cancer with an oncolytic virus May. 24, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to CGON
Number of mentions of CGON in WallStreetBets Daily Discussion
Recent picks made for CGON stock on CNBC
ETFs with the largest estimated holdings in CGON
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $CGON stock a Buy, Sell, or Hold?
- What is the price target for $CGON stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $CGON stock?
- Who owns the most shares of $CGON stock?
- What funds own $CGON stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CGON Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.